ES8701143A1 - Un procedimiento para la preparacion de nuevos aminas terciarias. - Google Patents

Un procedimiento para la preparacion de nuevos aminas terciarias.

Info

Publication number
ES8701143A1
ES8701143A1 ES545365A ES545365A ES8701143A1 ES 8701143 A1 ES8701143 A1 ES 8701143A1 ES 545365 A ES545365 A ES 545365A ES 545365 A ES545365 A ES 545365A ES 8701143 A1 ES8701143 A1 ES 8701143A1
Authority
ES
Spain
Prior art keywords
hydroxy
aryloxypropyl
substituted
hyperglycaemic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545365A
Other languages
English (en)
Other versions
ES545365A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8701143A1 publication Critical patent/ES8701143A1/es
Publication of ES545365A0 publication Critical patent/ES545365A0/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE NUEVAS AMINAS TERCIARIAS. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III) PARA OBTENER AMINAS TERCIARIAS DE FORMULA (I) O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES; DONDE R1 ES UN GRUPO 2-HIDROXI-2-(BENZOFURAN-2-IL)ETILO Y OTROS; R2 ES UN GRUPO DE HIDROGENO O UN GRUPO METILO; D ES UN RADICAL BENZOFURAN-2-ILO Y OTROS; R4 ES UN RADICAL -(CH2)ACOOH, -O(CH2)BCOOH Y OTROS; R4K ES UN ATOMO DE HIDROGENO O DE HALOGENO O UN RADICAL ALQUILO INFERIOR O ALCOXI INFERIOR Y OTROS; N ES 1 O 2; M ES 0 O 1, CON LA CONDICION DE QUE NBM ES 1 O 2; Q1 ES UN ATOMO DE HIDROGENO; Y Q2 ES UN GRUPO HIDROXI O UN ESTER HIDROLIZABLE IN-VIVO. TIENEN APLICACION EN MEDICINA Y AGRICULTURA POR SU ACTIVIDAD ANTI-HIPERGLICEMICA Y/O ANTI-OBESIDAD.
ES545365A 1984-07-19 1985-07-18 Un procedimiento para la preparacion de nuevos aminas terciarias. Expired ES8701143A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418472A GB8418472D0 (en) 1984-07-19 1984-07-19 Compounds

Publications (2)

Publication Number Publication Date
ES8701143A1 true ES8701143A1 (es) 1986-11-16
ES545365A0 ES545365A0 (es) 1986-11-16

Family

ID=10564149

Family Applications (2)

Application Number Title Priority Date Filing Date
ES545365A Expired ES8701143A1 (es) 1984-07-19 1985-07-18 Un procedimiento para la preparacion de nuevos aminas terciarias.
ES552860A Expired ES8705362A1 (es) 1984-07-19 1986-03-10 Un procedimiento para la preparacion de nuevas aminas terciarias

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES552860A Expired ES8705362A1 (es) 1984-07-19 1986-03-10 Un procedimiento para la preparacion de nuevas aminas terciarias

Country Status (11)

Country Link
EP (1) EP0170121B1 (es)
JP (1) JPS6176446A (es)
AT (1) ATE64590T1 (es)
AU (1) AU4517385A (es)
DE (1) DE3583261D1 (es)
DK (1) DK325385A (es)
ES (2) ES8701143A1 (es)
GB (1) GB8418472D0 (es)
GR (1) GR851779B (es)
PT (1) PT80835B (es)
ZA (1) ZA855400B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
GB8620951D0 (en) * 1986-08-29 1986-10-08 Beecham Group Plc Compounds
DE3866984D1 (en) * 1987-07-21 1992-01-30 Hoffmann La Roche Phenoxypropanolamine.
US5321036A (en) * 1993-02-10 1994-06-14 Bristol-Myers Squibb Company Thiazole and oxazole-based β3 adrenergic receptor agonists
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
US5563171A (en) * 1993-11-05 1996-10-08 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists
AU4320297A (en) * 1996-09-26 1998-04-17 Kissei Pharmaceutical Co. Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
DE3368258D1 (en) * 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines

Also Published As

Publication number Publication date
EP0170121B1 (en) 1991-06-19
PT80835A (en) 1985-08-01
DK325385A (da) 1986-01-20
PT80835B (en) 1987-03-23
JPS6176446A (ja) 1986-04-18
GR851779B (es) 1985-11-26
ES8705362A1 (es) 1987-05-01
DK325385D0 (da) 1985-07-17
EP0170121A1 (en) 1986-02-05
ES545365A0 (es) 1986-11-16
ZA855400B (en) 1986-05-28
AU4517385A (en) 1986-01-23
ES552860A0 (es) 1987-05-01
GB8418472D0 (en) 1984-08-22
ATE64590T1 (de) 1991-07-15
DE3583261D1 (de) 1991-07-25

Similar Documents

Publication Publication Date Title
DE68926403D1 (de) Peptid-Verbindungen, deren Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzung
ATE33835T1 (de) Verbindung mit antibronchopneumopathischer wirkung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
JPS6419071A (en) Amino acid derivative, production thereof and drug composition containing said derivative
HU908443D0 (en) Process for the production of peptides
SG15689G (en) Substituted acyl derivatives of 1,2,3,4-tetrahydroiso-quinoline-3-carboxylic acids,salts thereof,pharmaceutical compositions containing the derivatives or salts,and the production of the same
AU6128590A (en) Novel compounds
ES8302001A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalospirina.
ES8705362A1 (es) Un procedimiento para la preparacion de nuevas aminas terciarias
HUT50349A (en) Process for production of new cefem-compositions
ES8504682A1 (es) Un procedimiento para la preparacion de compuestos nitro alifaticos
HUT46895A (en) Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect
ATE71944T1 (de) Thiazolderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
DE3164314D1 (en) Azolylalkyl derivatives, process for their preparation and their use as fungicides
JPS5721400A (en) Novel fortimicin derivative
JPS54128592A (en) Cephalosporin derivatives and its preparation
ES8105734A1 (es) Un procedimiento para la preparacion de agentes antibacterianos beta-lactanicos.
CS321784A2 (en) Zpusiob vyroby l,3 bis(dimethylamino) 2 propyl 4 chlor fenoxyacetatu